Effects of Electronic Cigarette Settings and Liquid Concentrations in Cigarette Smokers and Electronic Cigarette Users

NCT03710590 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2022-10-06

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to find out how different types of electronic cigarettes (ECIG) settings, combined with e-liquids of differing nicotine concentrations, affect blood nicotine levels, use behavior (how users puff), and how users feel.

Conditions

  • Electronic Cigarettes

Interventions

OTHER

ECIG Lab Session 15 watts, 10 mg nicotine

During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.

OTHER

ECIG Lab Session 15 watts, 15 mg nicotine

During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.).

OTHER

ECIG Lab Session 15 watts, 30 mg nicotine

During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.

OTHER

ECIG Lab Session 30 watts, 10 mg nicotine

During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.

OTHER

ECIG Lab Session 30 watts, 15 mg nicotine

During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.

OTHER

ECIG Lab Session 30 watts, 30 mg nicotine

During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH
  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Alison Breland, PhD · Virginia Commonwealth University

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-15
Primary Completion
2020-03-09
Completion
2020-03-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03710590 on ClinicalTrials.gov